Skip to main content
. Author manuscript; available in PMC: 2016 Feb 29.
Published in final edited form as: P R Health Sci J. 2015 Sep;34(3):175–177.

Figure 1.

Figure 1

Percentage (%) of variance explained by covariates found to be significant predictors of warfarin dose variability in Puerto Ricans (i.e., genotypes, age, admixture, INR/dose on day 3 and amiodarone).